{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:29:35Z","timestamp":1792553375270,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.euo.2021.02.007","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T17:26:56Z","timestamp":1617384416000},"page":"396-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Financial Toxicity Among Patients with Prostate, Bladder, and Kidney Cancer: A Systematic Review and Call to Action"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-8847","authenticated-orcid":false,"given":"Sumeet K.","family":"Bhanvadia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Psutka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine L.","family":"Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haryana M.","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishal","family":"Gyawali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia K.","family":"Morgans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Penson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2021.02.007_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100269","article-title":"Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutions","volume":"20","author":"Desai","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.euo.2021.02.007_bib0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","article-title":"The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient\u2019s experience","volume":"18","author":"Zafar","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.euo.2021.02.007_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JOP.091074","article-title":"Impact of the cost of cancer treatment: an Internet-based survey","volume":"6","author":"Markman","year":"2010","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.euo.2021.02.007_bib0020","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2015.64.6620","article-title":"Financial insolvency as a risk factor for early mortality among patients with cancer","volume":"34","author":"Ramsey","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2021.02.007_bib0025","article-title":"Distinct financial distress profiles in patients with breast cancer prior to and for 12 months following surgery","author":"Chan","year":"2020","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.euo.2021.02.007_bib0030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jpainsymman.2018.12.003","article-title":"Relationships between financial toxicity and symptom burden in cancer survivors: a systematic review","volume":"57","author":"Chan","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.euo.2021.02.007_bib0035","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw205","article-title":"Financial hardships experienced by cancer survivors: a systematic review","volume":"109","author":"Altice","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euo.2021.02.007_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018756","article-title":"Domains of health-related quality of life in age-related macular degeneration: a qualitative study in the Chinese cultural context","volume":"8","author":"Bian","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.euo.2021.02.007_bib0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s40271-016-0204-x","article-title":"A systematic review of financial toxicity among cancer survivors: we can\u2019t pay the co-pay","volume":"10","author":"Gordon","year":"2017","journal-title":"Patient"},{"key":"10.1016\/j.euo.2021.02.007_bib0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.oraloncology.2019.06.023","article-title":"Understanding financial toxicity in head and neck cancer survivors","volume":"95","author":"Mady","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.euo.2021.02.007_bib0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jso.25374","article-title":"Financial toxicity in cancer care: prevalence, causes, consequences, and reduction strategies","volume":"120","author":"Lentz","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.euo.2021.02.007_bib0060","first-page":"153","article-title":"The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment","volume":"68","author":"Carrera","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2021.02.007_bib0065","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/pon.5361","article-title":"Cancer survivors\u2019 experiences with financial toxicity: a systematic review and meta-synthesis of qualitative studies","volume":"29","author":"Zhu","year":"2020","journal-title":"Psychooncology"},{"key":"10.1016\/j.euo.2021.02.007_bib0070","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/pros.21161","article-title":"The burden of out-of-pocket and indirect costs of prostate cancer","volume":"70","author":"Jayadevappa","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2021.02.007_bib0075","article-title":"Financial toxicity: a potential side effect of prostate cancer treatment among Australian men","volume":"26","author":"Gordon","year":"2017","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.euo.2021.02.007_bib0080","first-page":"1077","article-title":"Financial and family burden associated with cancer treatment in Ontario, Canada","volume":"14","author":"Longo","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.euo.2021.02.007_bib0085","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/07347332.2018.1486937","article-title":"Exploring the impact of out-of-pocket costs on the quality of life of Canadian cancer patients","volume":"36","author":"Fitch","year":"2018","journal-title":"J Psychosoc Oncol"},{"key":"10.1016\/j.euo.2021.02.007_bib0090","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2021.02.007_bib0095","doi-asserted-by":"crossref","first-page":"S316","DOI":"10.1016\/j.jamcollsurg.2019.08.690","article-title":"Cross-sectional study evaluating financial toxicity among bladder cancer patients","volume":"229","author":"Ehlers","year":"2019","journal-title":"J Am Coll Surg"},{"issue":"6_suppl","key":"10.1016\/j.euo.2021.02.007_bib0100","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2020.38.6_suppl.460","article-title":"Impact of bladder cancer stage on work impairment and financial toxicity","volume":"38","author":"Filippou","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2021.02.007_bib0105","first-page":"1703","article-title":"Financial toxicity and its associations with health-related quality of life among urologic cancer patients in an upper middle-income country","volume":"28","author":"Ting","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.euo.2021.02.007_bib0110","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.clgc.2014.08.013","article-title":"Treatment patterns and costs for metastatic renal cell carcinoma patients with private insurance in the United States","volume":"13","author":"Geynisman","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euo.2021.02.007_bib0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3747\/co.20.1197","article-title":"Responses by breast and prostate cancer patients to out-of-pocket costs in Newfoundland and Labrador","volume":"20","author":"Housser","year":"2013","journal-title":"Curr Oncol"},{"key":"10.1016\/j.euo.2021.02.007_bib0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.2018.36.7_suppl.145","article-title":"Material and behavioral financial hardship as predictors of health-related quality of life in a diverse cohort of cancer survivors","volume":"36","author":"Hastert","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2021.02.007_bib0125","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1158\/1055-9965.EPI-18-1336","article-title":"Financial hardship and quality of life among African American and white cancer survivors: the role of limiting care due to cost","volume":"28","author":"Hastert","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euo.2021.02.007_bib0130","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.juro.2017.10.049","article-title":"Financial toxicity among patients with bladder cancer: reasons for delay in care and effect on quality of life","volume":"199","author":"Casilla-Lennon","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2021.02.007_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176470","article-title":"Financial distress in patients with advanced cancer","volume":"12","author":"Barbaret","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2021.02.007_bib0140","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1634\/theoncologist.2018-0353","article-title":"Inequalities in financial distress, symptoms, and quality of life among patients with advanced cancer in France and the U.S","volume":"24","author":"Barbaret","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.euo.2021.02.007_bib0145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/07347332.2018.1504851","article-title":"Exploring the role of psychosocial care in value-based oncology: results from a survey of 3000 cancer patients and survivors","volume":"37","author":"Doherty","year":"2019","journal-title":"J Psychosoc Oncol"},{"key":"10.1016\/j.euo.2021.02.007_bib0150","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1080\/0284186X.2019.1592218","article-title":"The association of financial difficulties and out-of-pocket payments with health-related quality of life among breast, prostate and colorectal cancer patients","volume":"58","author":"Koskinen","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.euo.2021.02.007_bib0155","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11764-019-00764-y","article-title":"Race, financial hardship, and limiting care due to cost in a diverse cohort of cancer survivors","volume":"13","author":"Hastert","year":"2019","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.euo.2021.02.007_bib0160","doi-asserted-by":"crossref","first-page":"C55","DOI":"10.1158\/1538-7755.DISP17-C55","article-title":"Understanding the financial consequences of cancer: a qualitative study of racially and geographically diverse survivors","volume":"27","author":"Hastert","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euo.2021.02.007_bib0165","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1158\/1055-9965.EPI-13-0421","article-title":"Impact of rural residence on forgoing healthcare after cancer because of cost","volume":"22","author":"Palmer","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euo.2021.02.007_bib0170","first-page":"1411","article-title":"Exploring cancer support needs for older African-American men with prostate cancer","volume":"19","author":"Jones","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.euo.2021.02.007_bib0175","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/cncr.29808","article-title":"Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors","volume":"122","author":"Kale","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2021.02.007_bib0180","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/pon.3055","article-title":"Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer","volume":"22","author":"Sharp","year":"2013","journal-title":"Psychooncology"},{"key":"10.1016\/j.euo.2021.02.007_bib0185","first-page":"699","article-title":"Pre-diagnosis employment status and financial circumstances predict cancer-related financial stress and strain among breast and prostate cancer survivors","volume":"24","author":"Sharp","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.euo.2021.02.007_bib0190","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s11764-019-00803-8","article-title":"A meta-review of qualitative research on adult cancer survivors: current strengths and evidence gaps","volume":"13","author":"Laidsaar-Powell","year":"2019","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.euo.2021.02.007_bib0195","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJMp1306826","article-title":"Full disclosure\u2014out-of-pocket costs as side effects","volume":"369","author":"Ubel","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2021.02.007_bib0200","article-title":"Income-based disparities in financial burdens of medical spending under the Affordable Care Act in families with individuals having chronic conditions","volume":"56","author":"Xu","year":"2019","journal-title":"Inquiry"},{"key":"10.1016\/j.euo.2021.02.007_bib0205","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1200\/JCO.2009.23.1183","article-title":"American Society of Clinical Oncology guidance statement: the cost of cancer care","volume":"27","author":"Meropol","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2021.02.007_bib0210","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1200\/jco.2013.31.15_suppl.6512","article-title":"Determining value of high cost cancer therapies and discussing cost of cancer care: the patient perspective","volume":"31","author":"Rajguru","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2021.02.007_bib0215","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jama.290.7.953","article-title":"Patient-physician communication about out-of-pocket costs","volume":"290","author":"Alexander","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2021.02.007_bib0220","first-page":"5709","article-title":"Cost health literacy as a physician skill-set: the relationship between oncologist reported knowledge and engagement with patients on financial toxicity","volume":"28","author":"Fischer","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.euo.2021.02.007_bib0225","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1200\/JOP.18.00618","article-title":"Conversations about financial issues in routine oncology practices: a multicenter study","volume":"15","author":"Warsame","year":"2019","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.euo.2021.02.007_bib0230","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamaoncol.2016.4865","article-title":"Out-of-pocket spending and financial burden among Medicare beneficiaries with cancer","volume":"3","author":"Narang","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2021.02.007_bib0235","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1377\/hlthaff.2014.0801","article-title":"For uninsured cancer patients, outpatient charges can be costly, putting treatments out of reach","volume":"34","author":"Dusetzina","year":"2015","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.euo.2021.02.007_bib0240","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.amjmed.2018.05.020","article-title":"Death or debt? National estimates of financial toxicity in persons with newly-diagnosed cancer","volume":"131","author":"Gilligan","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.euo.2021.02.007_bib0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.juro.2017.10.039","article-title":"Addressing financial toxicity: the role of the urologist","volume":"200","author":"Mossanen","year":"2018","journal-title":"J Urol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931121000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931121000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:47:25Z","timestamp":1762876045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931121000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2588931121000419"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2021.02.007","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Financial Toxicity Among Patients with Prostate, Bladder, and Kidney Cancer: A Systematic Review and Call to Action","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2021.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}